DJIA 18,034.93 208.63 1.17%
NASDAQ 4,994.60 62.79 1.27%
S&P 500 2,100.40 19.22 0.92%
market minute promo

MannKind Corp (NASDAQ: MNKD)

4.93 -0.11 (-2.18%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MNKD $4.93 -2.18%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.05
Previous Close $5.04
Daily Range $4.90 - $5.09
52-Week Range $4.45 - $11.48
Market Cap $2.0B
P/E Ratio -9.88
Dividend (Yield) $0.00 (0.0%)
Volume 5,367,779
Average Daily Volume 3,708,354
Current FY EPS -$0.34




Drug Makers

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website:

News & Commentary Rss Feed

Pain-Free Blood Tests? Sign Me Up!

A small, Wisconsin-based company could be on the verge of developing a revolutionary new blood test that is virtually pain-free. Find out how personalized healthcare is transforming the medical field.

8 Analyst Stocks Under $10 With Massive Upside Calls

What's Afrezza's Ultimate Potential For MannKind?

Colorectal cancer biotech Xbiotech prices $76 million IPO at $19 midpoint

Short Sellers Increase Their Bets Against Biotech Stocks

Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind

MNKD May 29th Options Begin Trading

MannKind Corporation Shares Were Rocked in March -- Here's Why

MannKind stock was hammered in March. Find out what caused shares to lose 20% of their value and whether this dip represents a genuine buying opportunity.

'Mad Money' Lightning Round: Avoid MannKind and Alibaba

Play Alibaba Through Yahoo - Cramer's Lightning Round (4/7/15)

See More MNKD News...

MNKD's Top Competitors

MNKD $4.93 (-2.18%)
Current stock: MNKD
AMGN $165.97 (1.46%)
Current stock: AMGN
GILD $100.66 (-0.72%)
Current stock: GILD
BIIB $422.92 (0.83%)
Current stock: BIIB